Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DISHMAN PHARMA   ACTAVIS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ACTAVIS
Dec-18
DISHMAN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs37416,126-   
Low Rs12910,818-   
Sales per share (Unadj.) Rs197.03,955.8-  
Earnings per share (Unadj.) Rs21.2-1,274.2-  
Cash flow per share (Unadj.) Rs34.7416.9-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.916,315.7-  
Shares outstanding (eoy) m80.70332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 37.5%   
Avg P/E ratio x11.9-10.6 -112.3%  
P/CF ratio (eoy) x7.332.3 22.4%  
Price / Book Value ratio x1.40.8 169.4%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3074,480,758 0.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m5,3550-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m15,8981,315,689 1.2%  
Other income Rs m26525,160 1.1%   
Total revenues Rs m16,1631,340,849 1.2%   
Gross profit Rs m4,10334,478 11.9%  
Depreciation Rs m1,091562,428 0.2%   
Interest Rs m94475,923 1.2%   
Profit before tax Rs m2,334-578,713 -0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m624-7,334 -8.5%   
Profit after tax Rs m1,710-423,784 -0.4%  
Gross profit margin %25.82.6 984.9%  
Effective tax rate %26.71.3 2,108.7%   
Net profit margin %10.8-32.2 -33.4%  
BALANCE SHEET DATA
Current assets Rs m11,018539,627 2.0%   
Current liabilities Rs m9,517477,372 2.0%   
Net working cap to sales %9.44.7 199.5%  
Current ratio x1.21.1 102.4%  
Inventory Days Days5720 291.1%  
Debtors Days Days366 5.3%  
Net fixed assets Rs m18,787148,929 12.6%   
Share capital Rs m1610-   
"Free" reserves Rs m14,3540-   
Net worth Rs m14,5165,426,601 0.3%   
Long term debt Rs m4,1891,910,903 0.2%   
Total assets Rs m29,8058,483,012 0.4%  
Interest coverage x3.5-6.6 -52.4%   
Debt to equity ratio x0.30.4 82.0%  
Sales to assets ratio x0.50.2 343.9%   
Return on assets %8.9-4.1 -217.2%  
Return on equity %11.8-7.8 -150.9%  
Return on capital %17.5-4.8 -362.0%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786470,046 0.6%  
From Investments Rs m-1,529258,229 -0.6%  
From Financial Activity Rs m-941-806,740 0.1%  
Net Cashflow Rs m317-78,073 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DISHMAN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DISHMAN PHARMA With: AJANTA PHARMA  SUPRIYA LIFESCIENCE   PIRAMAL PHARMA  SEQUENT SCIENTIFIC  BETA DRUGS   



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.